Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 26, 2015 - Issue 2
Submit an article Journal homepage
212
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Thalidomide: Still an important second-line treatment in refractory cutaneous lupus erythematosus?

Isabelle BaretDepartment of Dermatology, University Hospital Leuven, Leuven, BelgiumCorrespondence[email protected]
&
Petra De HaesDepartment of Dermatology, University Hospital Leuven, Leuven, Belgium
Pages 173-177 | Received 27 Jan 2014, Accepted 11 Mar 2014, Published online: 14 Apr 2014

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Karishma Desai & Mariya Miteva. (2021) Recent Insight on the Management of Lupus Erythematosus Alopecia. Clinical, Cosmetic and Investigational Dermatology 14, pages 333-347.
Read now
Joshua Chang & Victoria P. Werth. (2016) Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects. Expert Review of Clinical Immunology 12:10, pages 1109-1121.
Read now

Articles from other publishers (13)

Graciela S. Alarcón, Mario H. Cardiel, Ariel Izcovich, Morton Scheinberg & Bernardo A. Pons-Estel. (2022) A Critical Analysis of the First Latin American Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus. JCR: Journal of Clinical Rheumatology 28:1, pages e312-e316.
Crossref
Emily Figueiredo Neves Yuki, Clovis A. Silva, Nadia E. Aikawa, Ricardo Romiti, Carlos Otto Heise, Eloisa Bonfa & Sandra Gofinet Pasoto. (2021) Thalidomide and Lenalidomide for Refractory Systemic/Cutaneous Lupus Erythematosus Treatment. JCR: Journal of Clinical Rheumatology 27:6, pages 248-259.
Crossref
Kathryn M. Kingsmore, Peter E. Lipsky & Amrie C. Grammer. 2021. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 641 652 .
Amy J. Petty, Lauren Floyd, Christopher Henderson & Matilda W. Nicholas. (2020) Cutaneous Lupus Erythematosus: Progress and Challenges. Current Allergy and Asthma Reports 20:5.
Crossref
J.L. Fairley, S. Oon, A.M. Saracino & M. Nikpour. (2020) Management of cutaneous manifestations of lupus erythematosus: A systematic review. Seminars in Arthritis and Rheumatism 50:1, pages 95-127.
Crossref
Kristen L. Chen, Rebecca L. Krain & Victoria P. Werth. (2019) Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus. F1000Research 8, pages 332.
Crossref
Swamy Venuturupalli & Daniel J. Wallace. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes 689 701 .
François Chasset, Toufik Tounsi, Elise Cesbron, Annick Barbaud, Camille Francès & Laurent Arnaud. (2018) Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 78:2, pages 342-350.e4.
Crossref
Fnu Nutan & Alex G. Ortega-Loayza. (2017) Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options. Journal of Investigative Dermatology Symposium Proceedings 18:2, pages S64-S68.
Crossref
A. Kuhn, E. Aberer, Z. Bata‐Csörgő, M. Caproni, A. Dreher, C. Frances, R. Gläser, H.‐W. Klötgen, A. Landmann, B. Marinovic, F. Nyberg, R. Olteanu, A. Ranki, J.C. Szepietowski & B. Volc‐Platzer. (2016) S2k guideline for treatment of cutaneous lupus erythematosus – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). Journal of the European Academy of Dermatology and Venereology 31:3, pages 389-404.
Crossref
Sara S. McCoy, Jasmine Stannard & J. Michelle Kahlenberg. (2016) Targeting the inflammasome in rheumatic diseases. Translational Research 167:1, pages 125-137.
Crossref
Amrie C. Grammer, Matthew M. Ryals, Michelle D. Catalina & Peter E. Lipsky. 2016. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 567 575 .
. (2016) Thalidomide. Reactions Weekly 1583:1, pages 1050-1050.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.